Peter Van Vlasselaer
Venture Partner at +ND Capital
About
Peter joined +ND Capital in 2019 and was previously founder and CEO of ARMO Biosciences (acquired by Eli Lilly). He has led and co-founded multiple biotech companies and holds a PhD in Immunology.
Colleagues at +ND Capital
Alison Palmer
Vice President of the General Partner at +ND Capital
André Châtelain
Advisor at +ND Capital
Aymeric Sallin
Founder and CEO at +ND Capital
Carl Pabo
Advisor at +ND Capital
Cathleen O’Connor
Executive Assistant at +ND Capital
Eric Moessinger
Partner at +ND Capital
Gabriela Ecco
Principal at +ND Capital
Jonathan Nicholson
Executive Director of the General Partner at +ND Capital